| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |